SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $460,000 | – | 13,589 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |